Neurodegeneration with brain iron accumulation (NBIA), is a heterogeneous group of rare genetic disorders characterised by accumulation of iron in the basal ganglia, which result in variable neurological disorders including extrapyramidal symptoms, neuropsychiatric and visual.
Numerous genes (at least 10) have been identified, resulting in a variety of specific diseases 3:
pantothenate kinase-associated neurodegeneration (PKAN)
- most common form accounting for 35-50% of NBIA
- previously known as Hallervorden-Spatz syndrome
PLA2G6-associated neurodegeneration (PLAN)
- accounts for ~20% of NBIA
mitochondrial membrane protein-associated neurodegeneration (MPAN)
- accounts for ~6-10% of NIBA
beta-propeller protein-associated neurodegeneration (BPAN)
- accounts of 1-2% of NIBA
- infantile neuroaxonal dystrophy (INAD) / atypical neuroaxonal dystrophy (NAD)
- COASY protein-associated neurodegeneration (COPAN)
- fatty acid hydroxylase-associated neurodegeneration (FAHN)
- Kufor-Rakeb syndrome
- Woodhouse-Sakati syndrome
No single demographic is affected, and epidemiology varied depending on the specific condition, ranging from infancy to old age 3.
Patients with NBIA suffer from a variety of neurological symptoms and signs including 3:
- extrapyramidal symptoms
- dystonia, muscular rigidity, spasms, parkinsonisms
- optic atrophy
- retinal degeneration
Radiographic features will vary among the various entities, but can broadly be thought of as 3:
- basal ganglia signal abnormalities
- cerebellar and cerebral atrophy
Treatment and prognosis
Although therapies will vary, dystonia is being treated with deep brain stimulation as well as oral or intrathecal baclofen 3.
Renewed interest in iron chelation is now present with the development of deferiprone 3.
- 1. Ebrahimi-Fakhari D. Autophagy and neurodegeneration - genetic findings in SENDA syndrome, a subtype of neurodegeneration with brain iron accumulation, provide a novel link. Mov. Disord. 2013;28 (8): 1050. doi:10.1002/mds.25563 - Pubmed citation
- 2. Schneider SA, Dusek P, Hardy J et-al. Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). Curr Neuropharmacol. 2013;11 (1): 59-79. doi:10.2174/157015913804999469 - Free text at pubmed - Pubmed citation
- 3. Gregory A. Hayflick S. Neurodegeneration with Brain Iron Accumulation Disorders Overview. GeneReviews, Seattle (WA): University of Washington, Seattle; 1993-2016. Full text online